Boehringer's operating income up 20.7 percent on Sanofi deal [Reuters]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Reuters
Boehringer's operating income up 20.7 percent on Sanofi deal | Reuters Reuters Staff 2 Min Read FRANKFURT, April 25 (Reuters) - Boehringer Ingelheim, Germany’s second-largest drugmaker, posted a gain in operating income of 20.7 percent to 3.5 billion euros ($4.27 billion) last year, boosted by the purchase of Sanofi’s veterinary medicine. Full-year sales increased 13.9 percent to 18.1 billion euros, it said in a statement on Wednesday. That translates to a gain of 4.4 percent when excluding the effects of the Sanofi transaction, which was wrapped up at the beginning of 2017. The asset swap saw unlisted Boehringer take Sanofi’s $13.5 billion animal health subsidiary, making it the world’s second-largest player in the industry after Zoetis. In return, Sanofi obtained the German company’s consumer health care business unit, valued at nearly $8 billion, plus $5.5 billion in cash from Boehringer, which Boehringer at the time paid largely from existing liquidity on its balance sheet. The ma
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Bankruptcy allowed Mallinckrodt to end Acthar royalties, 3rd Circ. rules [Reuters]Reuters
- EXPLAINER-What to know about bird flu in dairy cows and the risk to humans [Yahoo! Finance]Yahoo! Finance
- Sanofi (SNY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up [Yahoo! Finance]Yahoo! Finance
- AbbVie reports positive results from Rinvoq versus Dupixent study [Seeking Alpha]Seeking Alpha
SNY
Analyst Actions
- 2/12/24 - TheStreet
SNY
Sec Filings
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- 4/4/24 - Form S-8
- SNY's page on the SEC website